Skip to content
OpenCapital
Get started

JELD-WEN JELD Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By segment

See full
North America17%-10.5%

Other financials

Income statement

See full
Revenue$722.1M-6.9%
Gross profit$92.7M-17.3%
Operating income-$55.2M+70.1%
Net income-$76.8M+59.6%
EPS (diluted)-$0.90+59.8%

Balance sheet

See full
Cash & equivalents$52.3M-60.7%
Total debt$1.4B+6.3%
Total equity$12.2M-97.3%
Total assets$2.1B-14.1%

Cash flow

See full
Operating cash flow-$91.2M-9.2%
CapEx$25.1M-31.7%
Free cash flow-$116.3M+3.3%

Valuation

See full
Market cap$124.06M-62.0%
Enterprise value$1.5B-5.7%
P/S0×-0.1×

Profitability

See full
Gross margin15.7%-1.8pp
Operating margin-9.1%+1.6pp
Net margin-16.1%+29.2pp
FCF margin5.4%—

Returns & leverage

See full
Return on equity-218.8%-332pp
Debt / equity117.6×+115×
Current ratio1.7×-0.2×